United States: a vaccine against influenza A in a nasal spray

Overseas, a vaccine against H1N1 draws particular attention because of its mode of administration by nasal voice.

It is called FluMist and the United States, everyone knows his name. It is the only vaccine against influenza A which is administered by nasal voice as a spray.

There, the vaccination campaign began on October 5. And the first to have seen immunized by nasal spray are personal health.

But not everyone can benefit. Indeed, immunocompromised persons, pregnant women, children under 2 years asthmatics but also people suffering from heart disease, allergies to eggs and respiratory problems should not be vaccinated with FluMist.

According to Le Figaro published today, the vaccine is made ​​from live attenuated virus in which unlike other viruses are inactivated. It is for this reason that the European health authorities have not allowed our market. "It raises security concerns regarding in particular viral strain stability," says the newspaper quoted a sentence from the book "The flu face" published by Xavier Montauban.

This is the classic English syringe that will be vaccinated against the flu from today. For them too, the order of those priorities was established. It is like in France, health professionals and pregnant women.

"Our best line of defense against the flu is the vaccine," said Andy Burnham, the British Secretary of State for Health.